TY - JOUR
T1 - Ethnic Differences in Thrombotic Profiles of Acute Coronary Syndrome Patients and Relationship to Cardiovascular Outcomes
T2 - A Comparison of East Asian and White subjects
AU - Suh, Jung Won
AU - Memtsas, Vassilios
AU - Gue, Ying X.
AU - Cho, Hyoung Won
AU - Lee, Wonjae
AU - Kang, Si Hyuck
AU - Gorog, Diana A.
N1 - Publisher Copyright:
© 2024 Georg Thieme Verlag. All rights reserved.
PY - 2024/5/24
Y1 - 2024/5/24
N2 - Background East Asians (EAs), compared to white Caucasians (W), have a lower risk of ischemic heart disease and a higher risk of bleeding with antithrombotic medications. The underlying mechanisms are incompletely understood. Objectives We sought to compare thrombotic profiles of EA and W patients with myocardial infarction (MI) and relate these to cardiovascular outcomes. Methods In a prospective study in the United Kingdom and Korea, blood samples from patients (n = 515) with ST- or non-ST-elevation MI (STEMI and NSTEMI) were assessed using the Global Thrombosis Test, measuring thrombotic occlusion (OT) and endogenous fibrinolysis (lysis time [LT]). Patients were followed for 1 year for major adverse cardiovascular events (MACE) and bleeding. Results EA patients showed reduced OT (longer OT) compared to W (646 seconds [470 818] vs. 436 seconds [320 580], p < 0.001), with similar LT. In STEMI, OT (588 seconds [440 759] vs. 361 seconds [274 462], p < 0.001) and LT (1,854 seconds [1,389 2,729] vs. 1,338 seconds [1,104 1,788], p < 0.001) were longer in EA than W. In NSTEMI, OT was longer (OT: 734 seconds [541 866] vs. 580 seconds [474 712], p < 0.001) and LT shorter (1519 seconds [1,058 2,508] vs. 1,898 seconds [1,614 2,806], p = 0.004) in EA than W patients. MACE was more frequent in W than EA (6.3 vs. 1.9%, p = 0.014) and bleeding infrequent. While OT was unrelated, LT was a strong independent predictor of MACE event after adjustment for risk factors (hazard ratio: 3.70, 95% confidence interval: 1.43 9.57, p = 0.007), predominantly in W patients, and more so in STEMI than NSTEMI patients. Conclusion EA patients exhibit different global thrombotic profiles to W, associated with a lower rate of cardiovascular events.
AB - Background East Asians (EAs), compared to white Caucasians (W), have a lower risk of ischemic heart disease and a higher risk of bleeding with antithrombotic medications. The underlying mechanisms are incompletely understood. Objectives We sought to compare thrombotic profiles of EA and W patients with myocardial infarction (MI) and relate these to cardiovascular outcomes. Methods In a prospective study in the United Kingdom and Korea, blood samples from patients (n = 515) with ST- or non-ST-elevation MI (STEMI and NSTEMI) were assessed using the Global Thrombosis Test, measuring thrombotic occlusion (OT) and endogenous fibrinolysis (lysis time [LT]). Patients were followed for 1 year for major adverse cardiovascular events (MACE) and bleeding. Results EA patients showed reduced OT (longer OT) compared to W (646 seconds [470 818] vs. 436 seconds [320 580], p < 0.001), with similar LT. In STEMI, OT (588 seconds [440 759] vs. 361 seconds [274 462], p < 0.001) and LT (1,854 seconds [1,389 2,729] vs. 1,338 seconds [1,104 1,788], p < 0.001) were longer in EA than W. In NSTEMI, OT was longer (OT: 734 seconds [541 866] vs. 580 seconds [474 712], p < 0.001) and LT shorter (1519 seconds [1,058 2,508] vs. 1,898 seconds [1,614 2,806], p = 0.004) in EA than W patients. MACE was more frequent in W than EA (6.3 vs. 1.9%, p = 0.014) and bleeding infrequent. While OT was unrelated, LT was a strong independent predictor of MACE event after adjustment for risk factors (hazard ratio: 3.70, 95% confidence interval: 1.43 9.57, p = 0.007), predominantly in W patients, and more so in STEMI than NSTEMI patients. Conclusion EA patients exhibit different global thrombotic profiles to W, associated with a lower rate of cardiovascular events.
KW - East Asian
KW - ethnicity
KW - fibrinolysis
KW - myocardial infarction
KW - thrombotic status
UR - http://www.scopus.com/inward/record.url?scp=85183707069&partnerID=8YFLogxK
U2 - 10.1055/s-0043-1777794
DO - 10.1055/s-0043-1777794
M3 - Article
C2 - 38158199
AN - SCOPUS:85183707069
SN - 0340-6245
VL - 124
SP - 501
EP - 516
JO - Thrombosis and Haemostasis
JF - Thrombosis and Haemostasis
IS - 6
ER -